BN Business News
会社を追加 →
この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。

エネルギーと環境 · 2005/2/282 分で読めます

Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

ローカル自動翻訳 · 情報源の原言語

概要

The U.S. Nuclear Regulatory Commission will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 20 and 21, 2005. A sample of agenda items to be discussed during the public sessions includes: (1) Status of Rulemaking: Pt. 35 Training and Experience; (2) Status and Update: Redefining Medical Events; (3) Case Experience in Using I-125 Seeds as Markers; (4) FDA Radiation Dose Limits for Human Research Subjects Using Certain Radiolabeled Drugs, and (5) Establishing Guidance on Exceeding Dose Limits for Members of the Public who would serve as Caregivers to Persons undergoing Radiopharmaceutical Therapy. To review the agenda, see http:// www.nrc.gov/reading-rm/doc-collections/acmui/agenda/ or contact [email protected]. Furthermore, the ACMUI will brief the Commission regarding its activities, on April 20, 2005. Purpose: Discuss issues related to 10 CFR 35, Medical Use of Byproduct Material. Dates and Times for Public Meetings: April 20, 2005, from 8 a.m. to 5 p.m.; and April 21, 2005, from 10 a.m. to 5 p.m. Address for Public Meetings: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. The precise room numb

情報源の原言語: Federal Register — Nuclear Regulatory Commission原文の発表を開く →

関連インサイト

ビジネスインサイト →